1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies
Authors
Keywords
-
Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 37, Issue 1, Pages 386-402
Publisher
Informa UK Limited
Online
2021-12-20
DOI
10.1080/14756366.2021.2015342
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis
- (2021) Nawaf A. Alsaif et al. BIOORGANIC CHEMISTRY
- New bis([1,2,4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and anticancer evaluation
- (2021) Mohammed M. Alanazi et al. BIOORGANIC CHEMISTRY
- Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19)
- (2021) Amr El-Demerdash et al. Biomolecules
- Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents
- (2021) Souad A. El-Metwally et al. BIOORGANIC CHEMISTRY
- Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site
- (2021) Ibrahim H. Eissa et al. BIOORGANIC CHEMISTRY
- Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies
- (2021) Deepa R. Parmar et al. BIOORGANIC CHEMISTRY
- Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase
- (2020) Ahmed Ismail et al. STEROIDS
- Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation
- (2020) Ibrahim.H. Eissa et al. BIOORGANIC CHEMISTRY
- Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme
- (2020) Khaled El-Adl et al. BIOORGANIC CHEMISTRY
- 1,3,4‐oxadiazole and its derivatives: A review on recent progress in anticancer activities
- (2020) Ankur Vaidya et al. Chemical Biology & Drug Design
- N ‐Substituted‐4‐phenylphthalazin‐1‐amine‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluation studies
- (2020) Khaled El‐Adl et al. ARCHIV DER PHARMAZIE
- Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma
- (2020) Ibrahim.H. Eissa et al. BIOORGANIC CHEMISTRY
- Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein
- (2020) Hesham A. El-Mahdy et al. LIFE SCIENCES
- Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents
- (2019) Wagdy M. Eldehna et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Synthesis, molecular modeling, in vivo study, and anticancer activity of 1,2,4‐triazole containing hydrazide–hydrazones derived from ( S )‐naproxen
- (2019) Muhammed İ. Han et al. ARCHIV DER PHARMAZIE
- Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR‐2 inhibitors
- (2019) Abdel‐Ghany A. El‐Helby et al. ARCHIV DER PHARMAZIE
- Benzoxazole/benzothiazole‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations
- (2019) Abdel‐Ghany A. El‐Helby et al. ARCHIV DER PHARMAZIE
- Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPARγ and SUR agonists
- (2019) Mohamed Ayman El-Zahabi et al. BIOORGANIC CHEMISTRY
- Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers
- (2019) Hazem A. Mahdy et al. BIOORGANIC CHEMISTRY
- Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site
- (2019) Guangcheng Wang et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site
- (2018) Guangcheng Wang et al. BIOORGANIC CHEMISTRY
- The challenge of drug resistance in cancer treatment: a current overview
- (2018) Michail Nikolaou et al. CLINICAL & EXPERIMENTAL METASTASIS
- Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors
- (2018) M.K. Ibrahim et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies
- (2018) Ahmed Sabt et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors
- (2018) Kamal M. El-Gamal et al. JOURNAL OF MOLECULAR STRUCTURE
- Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking
- (2018) Walaa M. El-Husseiny et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma
- (2018) Chaoxu Yang et al. Cancer Medicine
- Suitability of hepatocyte cell lines HepG2, AML12 and THLE-2 for investigation of insulin signalling and hepatokine gene expression
- (2018) Stephanie Sefried et al. Open Biology
- Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies
- (2017) Wagdy M. Eldehna et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016)
- (2017) Fan-Wei Peng et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas: Discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors
- (2015) Vera A. Machado et al. BIOORGANIC & MEDICINAL CHEMISTRY
- AACR Cancer Progress Report 2015
- (2015) J. Baselga et al. CLINICAL CANCER RESEARCH
- Synthesis of Some Novel 1,3,4-Thiadiazole Derivatives and Biological Screening for Anti-Microbial, Antifungal and Anthelmintic Activity
- (2015) Somnath Devidas Bhinge et al. PHARMACEUTICAL CHEMISTRY JOURNAL
- Comparison ofin silicotools for evaluating rat oral acute toxicity
- (2015) R. Gonella Diaza et al. SAR AND QSAR IN ENVIRONMENTAL RESEARCH
- Tivozanib: Status of Development
- (2015) Muhammad Omer Jamil et al. Current Oncology Reports
- Quantitation of VEGFR2 (vascular endothelial growth factor receptor) inhibitors - review of assay methodologies and perspectives
- (2014) Kuldeep Sharma et al. BIOMEDICAL CHROMATOGRAPHY
- Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma—Mechanistics, review of phase III randomized clinical trials, and regulatory implications
- (2013) Ramez N. Eskander et al. GYNECOLOGIC ONCOLOGY
- Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway
- (2013) Zhiyu Wang et al. PLoS One
- Vascular Endothelial Growth Factor (VEGF), VEGF Receptors and Their Inhibitors for Antiangiogenic Tumor Therapy
- (2011) Satoru Takahashi BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Vascular endothelial growth factor receptor-2 in breast cancer
- (2010) Shanchun Guo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The design, synthesis, and evaluation of 8 hybrid DFG-out allosteric kinase inhibitors: A structural analysis of the binding interactions of Gleevec®, Nexavar®, and BIRB-796
- (2010) Justin Dietrich et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors
- (2010) Kyungik Lee et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacophore modeling studies of type I and type II kinase inhibitors of Tie2
- (2008) Qing-Qing Xie et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
- (2008) Tuomas Tammela et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search